Characteristics | Level | Number (%) |
---|---|---|
Age at diagnosis | Mean ± SD | 71.41 ± 11.318 |
Median (range) | 71 (34–105) | |
≤ 70 | 8079 (48.5%) | |
> 70 | 8564 (51.5%) | |
Race | White | 12,367 (74.3%) |
Black | 303 (18.2%) | |
Asian or Pacific Islander | 989 (5.9%) | |
Others/unknown | 257 (1.5%) | |
Marital status | Married | 8987 (54.0%) |
Unmarried | 6542 (39.3%) | |
Unknown | 1114 (6.7%) | |
Tumor grade | Well differentiated | 96 (0.6%) |
Moderately differentiated | 861 (5.2%) | |
Poorly differentiated | 9097 (54.6%) | |
Undifferentiated | 87 (0.5%) | |
Unknown | 6502 (39.1%) | |
PSA | ≤ 10 ng/ml | 1271 (7.6%) |
10–20 ng/ml | 1240 (7.4%) | |
20–50 ng/ml | 2037 (12.2%) | |
> 50 ng/ml | 10,336 (62.1%) | |
Unknown | 1759 (10.6%) | |
Gleason | ≤ 6 | 219 (1.3%) |
3 + 4 | 536 (3.2%) | |
4 + 3 | 885 (5.3%) | |
8–10 | 8052 (48.4%) | |
Unknown | 6951 (41.8%) | |
Metastatic sites | Bone-only | 14,872 (89.4%) |
Bone and lung | 976 (5.9%) | |
Bone and liver | 414 (2.5%) | |
Bone and brain | 126 (0.8%) | |
Bone and ≥ 2 other sites | 255 (1.3%) | |
Surgery | Yes | 1593 (9.6%) |
No/unknown | 15,085 (90.4%) | |
Radiotherapy | Yes | 3765 (22.6%) |
No/unknown | 12,878 (77.4%) | |
Chemotherapy | Yes | 2216 (13.3%) |
No/unknown | 14,427 (86.7%) |